News

Phylogica will employ its proprietary Phylomer drug discovery platform to identify Phylomer peptides suitable for further evaluation. As per the agreement, Phylogica grants Pfizer certain rights, including an

The committee’s positive opinion will now be forwarded to the European Commission for ratification, which typically occurs within two to three months from adoption of the CHMP opinion.

CIT and Biomodels claim the synergy derived from this alliance will enable the two companies to provide their clients with a comprehensive and seamless program of pre-clinical drug

Neurotez has developed two Leptin products for the treatment of Alzheimer’s disease and other cognitive disorders for which the contract aims at manufacturing of one of the product.

Component is investigating the efficacy of vidofludimus in RA with methotrexate, compared to methotrexate alone. In the rial, a total of 244 RA patients were recruited for this

Under the agreement, EpiTherapeutics will receive an upfront payment as well as funding of research activities. In addition, under certain conditions, EpiTherapeutics is eligible to receive milestone payments

Novartis said that the investment is part of an overall $500m commitment in local infrastructure and collaborative healthcare initiatives planned over a five-year period. The partnership addresses three

Letendre will be responsible for spearheading the clinical, regulatory, IP and strategic direction of the company. Based on data from a pilot proof of concept (POC) study in

Superabsorbent polymers are plastics with the capacity to absorb up to 500 times their own weight in liquid. Superabsorbent polymers are mainly used to make diapers. Adult incontinence